Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Yoshikuni Mizuno »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yoshikino Mizuno < Yoshikuni Mizuno < Youenn Lajat  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000199 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000217 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000340 (2007) Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
000547 (1999) Etienne C. Hirsch [France] ; Stéphane Hunot [France] ; Baptiste Faucheux [France] ; Yves Agid [France] ; Yoshikuni Mizuno [Japon] ; Hideki Mochizuki [Japon] ; William G. Tatton [États-Unis] ; Nadine Tatton [États-Unis] ; Warren C. Olanow [États-Unis]Dopaminergic neurons degenerate by apoptosis in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
5Humans
4Parkinson's disease
3Aged
3Antiparkinson Agents (administration & dosage)
3Benzothiazoles (administration & dosage)
3Double-Blind Method
3Female
3Male
3Middle Aged
3Nervous system diseases
3Parkinson Disease (drug therapy)
3Parkinson disease
3Pramipexole
3Severity of Illness Index
2Antiparkinson Agents (adverse effects)
2Benzothiazoles (adverse effects)
2Delayed-Action Preparations (therapeutic use)
2Dopamine agonist
2Drug Administration Schedule
2Quality of Life
2Release
2dopamine agonist
1Activities of Daily Living
1Adult
1Antiparkinson Agents (therapeutic use)
1Apoptosis (genetics)
1Benzothiazoles (therapeutic use)
1Cognition Disorders (etiology)
1Cognition Disorders (psychology)
1Confidence Intervals
1DNA Fragmentation
1Delayed-Action Preparations (administration & dosage)
1Delayed-Action Preparations (adverse effects)
1Dementia (diagnosis)
1Dementia (etiology)
1Dementia (psychology)
1Dose-Response Relationship, Drug
1Drug Delivery Systems (methods)
1Evaluation
1In Situ Nick-End Labeling
1Levodopa (therapeutic use)
1Memory Disorders (etiology)
1Memory Disorders (psychology)
1Nerve Degeneration (pathology)
1PD dementia
1Pain Measurement
1Parkinson Disease (complications)
1Parkinson Disease (pathology)
1Parkinson Disease (psychology)
1Patient Satisfaction
1Psychomotor Performance (physiology)
1Safety
1Substantia Nigra (pathology)
1Terminology as Topic
1Time Factors
1Treatment
1Treatment Outcome
1clinical trial
1delayed‐start
1diagnostic criteria
1executive functions
1neuroprotection
1pramipexole
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1task force
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Yoshikuni Mizuno" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Yoshikuni Mizuno" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshikuni Mizuno
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024